Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.

Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 7 months. Both eyes will undergo cataract surgery. The second eye surgery will occur within 7 to 14 days of the first.

Key Inclusion Criteria:

• Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification);
• Subject must be able to understand and sign an approved informed consent form;
• Subject is willing to complete all the required study visits for the duration of the study;
• Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

• Ocular conditions as specified in the protocol;
• Subjects who desire monovision correction;
• Previous intraocular or corneal surgery;
• Other protocol-defined exclusion criteria may apply.